Edible traditional Chinese medicines improve type 2 diabetes by modulating gut microbiotal metabolites

被引:0
|
作者
Shen Chen
Yiqiao Jiao
Yiyang Han
Jie Zhang
Yuanyuan Deng
Zilu Yu
Jiao Wang
Shasha He
Wei Cai
Jixiong Xu
机构
[1] First Affiliated Hospital of Nanchang University,Department of Endocrinology and Metabolism
[2] Jiangxi Clinical Research Center for Endocrine and Metabolic Disease,Queen Mary School, Medical College
[3] Jiangxi Branch of National Clinical Research Center for Metabolic Disease,Department of Medical Genetics and Cell Biology
[4] Nanchang University,undefined
[5] Medical College of Nanchang University,undefined
来源
Acta Diabetologica | 2024年 / 61卷
关键词
T2DM; Edible traditional Chinese medicines; Gut microbiotal metabolites; Short-chain fatty acids; Bile acids; Branched-chain amino acids;
D O I
暂无
中图分类号
学科分类号
摘要
Type 2 diabetes mellitus (T2DM) is a metabolic disorder with intricate pathogenic mechanisms. Despite the availability of various oral medications for controlling the condition, reports of poor glycemic control in type 2 diabetes persist, possibly involving unknown pathogenic mechanisms. In recent years, the gut microbiota have emerged as a highly promising target for T2DM treatment, with the metabolites produced by gut microbiota serving as crucial intermediaries connecting gut microbiota and strongly related to T2DM. Increasingly, traditional Chinese medicine is being considered to target the gut microbiota for T2DM treatment, and many of them are edible. In studies conducted on animal models, edible traditional Chinese medicine have been shown to primarily alter three significant gut microbiotal metabolites: short-chain fatty acids, bile acids, and branched-chain amino acids. These metabolites play crucial roles in alleviating T2DM by improving glucose metabolism and reducing inflammation. This review primarily summarizes twelve edible traditional Chinese medicines that improve T2DM by modulating the aforementioned three gut microbiotal metabolites, along with potential underlying molecular mechanisms, and also incorporation of edible traditional Chinese medicines into the diets of T2DM patients and combined use with probiotics for treating T2DM are discussed.
引用
收藏
页码:393 / 411
页数:18
相关论文
共 50 条
  • [1] Edible traditional Chinese medicines improve type 2 diabetes by modulating gut microbiotal metabolites
    Chen, Shen
    Jiao, Yiqiao
    Han, Yiyang
    Zhang, Jie
    Deng, Yuanyuan
    Yu, Zilu
    Wang, Jiao
    He, Shasha
    Cai, Wei
    Xu, Jixiong
    ACTA DIABETOLOGICA, 2024, 61 (04) : 393 - 411
  • [2] Modulating the Gut Microbiota and Metabolites with Traditional Chinese Medicines: An Emerging Therapy for Type 2 Diabetes Mellitus and Its Complications
    Jiang, Peiyan
    Di, Zhenghan
    Huang, Wenting
    Xie, Lan
    MOLECULES, 2024, 29 (12):
  • [3] Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes
    Tiantian Zhu
    Mark O. Goodarzi
    Current Nutrition Reports, 2020, 9 : 83 - 93
  • [4] Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes
    Zhu, Tiantian
    Goodarzi, Mark O.
    CURRENT NUTRITION REPORTS, 2020, 9 (02) : 83 - 93
  • [5] Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism
    Li, Yingying
    Ji, Xinyu
    Wu, Haonan
    Li, Xiang
    Zhang, Huamin
    Tang, Danli
    JOURNAL OF ETHNOPHARMACOLOGY, 2021, 278
  • [6] Traditional Chinese medicine to improve immune imbalance of asthma: focus on the adjustment of gut microbiota
    Lu, Ke
    Li, Chen
    Men, Jingwen
    Xu, Bin
    Chen, Yang
    Yan, Peizheng
    Gai, Zhibo
    Zhang, Qingxiang
    Zhang, Lu
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [7] Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus
    Du, Leilei
    Li, Qi
    Yi, Huan
    Kuang, Tingting
    Tang, Yi
    Fan, Gang
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [8] Gut microbiota and its metabolites regulate insulin resistance: traditional Chinese medicine insights for T2DM
    Liu, Jing
    Li, Fuxing
    Yang, Le
    Luo, Shengping
    Deng, Yihui
    FRONTIERS IN MICROBIOLOGY, 2025, 16
  • [9] Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes
    Caesar, Robert
    CANADIAN JOURNAL OF DIABETES, 2019, 43 (03) : 224 - 231
  • [10] A Metabolite Perspective on the Involvement of the Gut Microbiota in Type 2 Diabetes
    Fu, Yifeng
    Li, Siying
    Xiao, Yunhua
    Liu, Gang
    Fang, Jun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)